Your browser doesn't support javascript.
loading
Guselkumab More Effectively Neutralizes Psoriasis-Associated Histologic, Transcriptomic, and Clinical Measures than Ustekinumab.
Campbell, Kim; Li, Katherine; Yang, Feifei; Branigan, Patrick; Elloso, M Merle; Benson, Jacqueline; Orlovsky, Yevgeniya; Chen, Yanqing; Garcet, Sandra; Krueger, James G.
Affiliation
  • Campbell K; Janssen Research & Development, LLC, Spring House, PA.
  • Li K; Janssen Research & Development, LLC, Spring House, PA.
  • Yang F; Janssen Research & Development, LLC, Spring House, PA.
  • Branigan P; Janssen Research & Development, LLC, Spring House, PA.
  • Elloso MM; Janssen Scientific Affairs, LLC, Horsham, PA.
  • Benson J; Janssen Research & Development, LLC, Spring House, PA.
  • Orlovsky Y; Janssen Research & Development, LLC, Spring House, PA.
  • Chen Y; Janssen Research & Development, LLC, Spring House, PA.
  • Garcet S; The Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY.
  • Krueger JG; The Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY.
Immunohorizons ; 7(4): 273-285, 2023 04 01.
Article in En | MEDLINE | ID: mdl-37071038
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Ustekinumab Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Immunohorizons Year: 2023 Document type: Article Affiliation country: Panama Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Ustekinumab Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Immunohorizons Year: 2023 Document type: Article Affiliation country: Panama Country of publication: United States